Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortec expanding cultured skin replacement burn study to five sites.

This article was originally published in The Gray Sheet

Executive Summary

ORTEC INTL.'S SKIN REPLACEMENT PRODUCT U.S. CLINICALS will be expanded to four additional burn centers in the next several months, according to the company. Patient enrollment in the 120-patient study of Ortec's Composite Cultured Skin (CCS) for treatment of severe burns already is under way at the initial site at Westchester Medical Center burn facility, Valhalla, New York. Negotiations for the remaining four trial sites are ongoing at burn centers in Connecticut, New Jersey and New York.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel